Boston Scientific (BSX) stock is currently trading around $49.01, retreating to its historical price range of $46.56 to $51.46, a range previously defended by buyers six times. However, management has lowered its adjusted earnings per share (EPS) guidance for fiscal year 2026 to $3.28-$3.32, primarily due to an unexpected sharp slowdown in its WATCHMAN heart device in the U.S. market and increased competition in its electrophysiology (EP) business. The company anticipates limited adjusted EPS growth in 2027, hoping for a rebound driven by new products in 2028.